The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic Retroviruses

  1. WARNER C. GREENE, M.D., Ph.D.;
  2. WARREN J. LEONARD, M.D.;
  3. JOEL M. DEPPER, M.D.;
  4. DAVID L. NELSON, M.D.; and
  5. THOMAS A. WALDMANN, M.D.
  1. Bethesda, Maryland

    Abstract

    The human receptor for interleukin-2 (T-cell growth factor) plays a critical role in the growth of T cells and is required for full expression of the normal immune response. Through hybridoma and recombinant DNA techniques, the interleukin-2 receptor protein has been biochemically characterized and purified; full-length copies of its complementary DNA have been molecularly cloned, sequenced, and expressed in eukaryotic cells; and the receptor gene has been characterized. Transient expression of the interleukin-2 receptor gene occurs during normal T-cell activation, and high- and low-affinity forms of the membrane receptor exist. A naturally occurring, soluble receptor has also been isolated, and its levels in serum correlate with the activity of various diseases. Deregulation of interleukin-2 receptor expression occurs in T-cell leukemias produced by the human T-lymphotropic retroviruses types l and ll (HTLV-l and -ll) and has been causally linked to the action of the trans-activator (tat) gene of these viruses. Monoclonal antibodies specific for the interleukin-2 receptor are being evaluated in the treatment of HTLV-l-induced leukemias and other conditions involving the inappropriate function of activated T cells.

    Article and Author Information

    • ▸An edited summary of a Combined Clinical Staff Conference held 26 March 1986 at the Amphitheater, Building 10, Bethesda, Maryland, sponsored by the National Institutes of Health, U.S. Department of Health and Human Services.

    • ▸Authors who wish to cite a section of the conference and specifically indicate its author can use this example for the form of reference.

      LEONARD WJ. Molecular and biochemical characterization of the human interleukin-2 receptor, pp 560-3. In: GREENE WC, moderator. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med. 1986;105:560-72.

    • ▸Requests for reprints should be addressed to Wendy L. Schubert, Sc.M.; Clinical Center Communications, Clinical Center, National Institutes of Health; Bethesda, MD 20892.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement